Similar results were published by Qiu et al. (2014), who confirmed significantly higher level of serum HMGB1 in patients with laryngeal cancer compared with the healthy controls (4.81 vs. 3.21 ng/mL, p < 0.001). Here, HMGB1 is linked to laryngeal carcinoma.